30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Longboard Pharmaceuticals Inc (LBPH)

Track

Stock chart
Ticker: LBPH Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Kaye Randall
CMO
1 sale — total 983,936 USD
Planned sale 15 Oct 2024
Value US$1,442,162.94 | Price 434.87 | Shares 251
Proposed sale 16 Sep 2024
Value US$4,359,638.65 | Price 414.40 | Shares 68,727
Planned sale 16 Sep 2024
Value US$64,668.21 | Price 34.04 | Shares 1,900
Planned sale 16 Sep 2024
Value US$39,749.52 | Price 33.12 | Shares 1,200
Planned sale 16 Sep 2024
Value US$133,622.16 | Price 31.81 | Shares 4,200
Planned sale 16 Sep 2024
Value US$289,278.28 | Price 30.89 | Shares 9,366
Planned sale 12 Aug 2024
Value US$216,856.49 | Price 35.03 | Shares 6,191
Planned sale 12 Aug 2024
Value US$361,947.90 | Price 34.55 | Shares 10,476
Proposed sale 12 Aug 2024
Value US$584,845.03 | Price 35.09 | Shares 16,667
Sale 25 Jun 2024
Value US$2,087.00 | Price 20.87 | Shares 100
Sale 25 Jan 2024
Value US$96,479,595.00 | Price 24.25 | Shares 3,978,540
Buy 23 Jan 2024
Value US$2,482.00 | Price 24.82 | Shares 100
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-10-16 2024-10-15 PlS Planned sale
1.0
Kaye Randall

CMO

Officer
251 +39.2%
434.87
US$1,442,163 		251 +39.2% 434.87 US$1,442,163
2024-09-16 2024-09-16 PrS Proposed sale
1.0
RANDALL KAYE

Officer

Officer
68,727
414.40
US$4,359,639 		68,727 414.40 US$4,359,639
2024-09-16 2024-09-16 PlS Planned sale
1.0
Kaye Randall

CMO

Officer
15,873 -15.8%
196.37
US$1,748,223 		15,873 -15.8% 196.37 US$1,748,223
2024-09-16 2024-09-16 PlS Planned sale
1.0
Kaye Randall

CMO

Officer
1,200 -5.7%
33.12
US$39,750 		1,200 -5.7% 33.12 US$39,750
2024-09-16 2024-09-16 PlS Planned sale
1.0
Kaye Randall

CMO

Officer
4,200 -16.7%
31.81
US$133,622 		4,200 -16.7% 31.81 US$133,622
2024-09-16 2024-09-16 PlS Planned sale
1.0
Kaye Randall

CMO

Officer
9,366 -27.1%
30.89
US$289,278 		9,366 -27.1% 30.89 US$289,278
2024-08-13 2024-08-12 PlS Planned sale
1.0
Kaye Randall

CMO

Officer
6,191 -25.7%
35.03
US$216,856 		6,191 -25.7% 35.03 US$216,856
2024-08-13 2024-08-12 PlS Planned sale
1.0
Kaye Randall

CMO

Officer
10,476 -30.3%
34.55
US$361,948 		10,476 -30.3% 34.55 US$361,948
2024-08-12 2024-08-12 PrS Proposed sale
1.0
RANDALL KAYE

Officer

Officer
16,667
35.09
US$584,845 		16,667 35.09 US$584,845
2024-08-13 2024-06-25 S Sale
1.0
Kaye Randall

CMO

Officer
100 -100.0%
20.87
US$2,087 		100 -100.0% 20.87 US$2,087
2024-01-29 2024-01-25 S Sale
3.0
ARENA PHARMACEUTICALS INC

Former 10% Owner
3,978,540 -100.0%
24.25
US$96,479,595 		3,978,540 -100.0% 24.25 US$96,479,595
2024-08-13 2024-01-23 B Purchase
1.0
Kaye Randall

CMO

Officer
100 +inf%
24.82
US$2,482 		100 +inf% 24.82 US$2,482
Explore more

More insider trading research around Longboard Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America